The effects of decorin and HGF-primed vocal fold fibroblasts in vitro and ex vivo in a porcine model of vocal fold scarring

Laryngoscope

Volumn 120, Issue 11, 2010, Pages 2247-2257

  Krishna, Priya ^a   Regner, Michael ^b   Palko, Joel ^c   Liu, Fang ^a   Abramowitch, Steve ^d   Jiang, Jack ^b   Wells, Alan ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d University of Pittsburgh   (United States)

Author keywords

laryngology; Molecular biology

Indexed keywords

COLLAGEN TYPE 1; DECORIN; EPIDERMAL GROWTH FACTOR; NEUTROPHIL COLLAGENASE; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LYSATE; CELL MIGRATION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; EX VIVO STUDY; FIBROBLAST; IN VITRO STUDY; LARYNX INJURY; NONHUMAN; PRIORITY JOURNAL; SCAR FORMATION; SWINE; VISCOELASTICITY; VOCAL CORD; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CICATRIX; DECORIN; DISEASE MODELS, ANIMAL; FIBROBLASTS; HEPATOCYTE GROWTH FACTOR; INJECTIONS, INTRALESIONAL; MICROSCOPY, CONFOCAL; RANDOM ALLOCATION; RHEOLOGY; TISSUE AND ORGAN HARVESTING; VOCAL CORDS;

EID: 78349259265     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.21087     Document Type: Article

References (23)

1. Hansen JK, Thibeault SL., Current understanding and review of the literature: vocal fold scarring. J Voice 2006; 20: 110-120.
2. Gray SD, Titze IR, Chan R, Hammond TH., Vocal fold proteoglycans and their influence on biomechanics. Laryngoscope 1999; 109: 845-854.
3. Pawlak AS, Hammond E, Hammond T, Gray SD., Immunocytochemical study of proteoglycans in vocal folds. Ann Otol Rhinol Laryngol 1996; 105: 6-11.
4. Krishna P, Rosen CA, Branski RC, Wells AH, Hebda PA., Primed fibroblasts and exogenous decorin: potential treatments for subacute vocal fold scar. Otolaryngol Head Neck Surg 2006; 135: 937-945.
5. Hirano S, Bless DM, Rousseau B, Welham N, Montequin D, Chan RW, Ford CN., Prevention of vocal fold scarring by topical injection of hepatocyte growth factor in a rabbit model. Laryngoscope 2004; 114: 548-556.
6. Liang C, Park AY, Guan J., In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protocols 2007; 2: 329-333.
7. Xu CC, Chan RW, Tirunagiri N., A biodegradeable, acellular xenogenic scaffold for regeneration of the vocal fold lamina propria. Tissue Eng 2007; 13: 551-566.
8. Jiang JJ, Titze IR,. A methodological study of hemilaryngeal phonation. Laryngoscope 1993; 103: 872-882.
9. Burridge K, Wennerber K,. Rho and Rac take center stage. Cell 2004; 116: 167-179.
10. Chan RW, Titze IR,. Viscoelastic shear properties of human vocal fold mucosa: measurement methodology and empirical results. J Acoust Soc Am 1999; 106 (Pt. 1): 2008-2021.
11. Rousseau B, Sohn J, Tateya I, Motequin DW, Bless DM,. Functional outcomes of reduced hyaluronan in acute vocal fold scar. Ann Otol Rhinol Laryngol 2004; 113: 767-776.
12. Tateya T, Sohn JH, Tateya I, Bless DM,. Histologic characterization of rat vocal fold scarring. Ann Otol Rhinol Laryngol 2005; 114: 183-191.
13. Hirano S,. Current treatment of vocal fold scarring. Curr Opin Otolaryngol Head Neck Surg 2005; 13: 143-147.
14. Douglas T, Heinemann S, Bierbaum S, Scharnweber D, Worch H,. Fibrillogenesis of collagen types I, II, and III with small leucine-rich proteoglycans decorin and biglycan. Biomacromolecules 2006; 7: 2388-2393.
15. Thibeault SL, Bless DM, Gray SD,. Interstitial protein alterations in rabbit vocal fold with scar. J Voice 2003; 17: 377-383.
16. Kinsella MG, BGressler SL, Wight TN,. The regulated synthesis of versican, decorin and biglycan: extracellular matrix proteoglycans that influence cellular phenotype. Crit Rev Euk Gene Exp 2004; 14: 203-234.
17. Ware MF, Wells A, Lauffenburger DA,. Epidermal growth factor alters fibroblast migration speed and directional persistence reciprocally and in a matrix-dependent manner. J Cell Sci 1998; 111: 2423-2432.
18. Imai K, Hiramatus A, Fukushima D, Pierschbacher M, Okada Y,. Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-β1 release. Biochem J 1997; 322: 809-814.
19. Verdolini K, Branski R, Rosen CA, Hebda PA,. Shifts in biochemical markers associated with wound healing in laryngeal secretions following phonotrauma: a preliminary study. Ann Otol Rhinol Laryngol 2003; 112: 1021-1025.
20. Rousseau B, Ge PJ, Ohno T, French LC, Thibeault SL,. Extracellular matrix gene expression after vocal fold injury in a rabbit model. Ann Otol Rhinol Laryngol 2008; 117: 598-603.
21. Tufvesson E, Westergren-Thorsson G,. Biglycan and decorin induce morphological and cytoskeletal changes involving signalling by the small GTPases RhoA and Rac1 resulting in lung fibroblast migration. J Cell Sci 2003; 116: 4857-4864.
22. Titze IR, Schmidt SS, Titze MR,. Phonation threshold pressure in a physical model of the vocal fold mucosa. J Acoust Soc Am 1995; 97 (Pt 1): 3080-3084.
23. Titze IR,. Principles of Voice Production. Englewood Cliffs, NJ: Prentice Hall; 1994.